PubMed=24324078
Moulay M., Liu W., Willenbrock S., Sterenczak K.A., Carlson R., Ngezahayo A., Murua Escobar H., Nolte I.
Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines.
Anticancer Res. 33:5421-5431(2013)

PubMed=26774145; DOI=10.4149/208_150924N505
Hammer S.C., Nagel S., Junginger J., Hewicker-Trautwein M., Wagner S., Heisterkamp A., Ngezahayo A., Nolte I., Murua Escobar H.
Claudin-1, -3, -4 and -7 gene expression analyses in canine prostate carcinoma and mammary tissue derived cell lines.
Neoplasma 63:231-238(2016)

PubMed=32168360; DOI=10.1371/journal.pone.0230272; PMCID=PMC7069630
Packeiser E.-M., Hewicker-Trautwein M., Thiemeyer H., Mohr A., Junginger J., Schille J.T., Murua Escobar H., Nolte I.
Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis.
PLoS ONE 15:e0230272.1-e0230272.25(2020)

PubMed=34972712; DOI=10.21873/invivo.12688; PMCID=PMC8765162
Alnajjar S., Nolte I., Schille J.T., Sender S., Trakoolju N., Perez S.V., Zechner D., Vollmar B., Junghanss C., Murua Escobar H.
Establishment and characterization of FusionRed stable transfected canine prostate adenocarcinoma and transitional cell carcinoma cells.
In Vivo 36:170-179(2022)

PubMed=35109825; DOI=10.1186/s12935-021-02422-9; PMCID=PMC8812184
Packeiser E.-M., Taher L., Kong W.-B., Ernst M., Beck J., Hewicker-Trautwein M., Brenig B., Schutz E., Murua Escobar H., Nolte I.
RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures.
Cancer Cell Int. 22:54.1-54.21(2022)